HIGHLIGHTS
- who: Benjamin Havenga and colleagues from the Department of Microbiology, Faculty of Science, Stellenbosch University, Private Bag , have published the research work: Biological Control of Acinetobacter baumannii: In Vitro and In Vivo Activity, Limitations, and Combination Therapies, in the Journal: Microorganisms 2022, 1052 of /2022/
- how: Indicated that the crude surfactin (C13-16 surfactin analogue) extract (10.00 mg/mL) retained antimicrobial activity against all (100%) A. baumannii P. aeruginosa E. coli and K. pneumoniae strains classified as MDR XDR and colistin resistant. Indicated that the AB1801 bacteriophage was capable of inhibiting biofilm formation by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.